MEDONLY, founded in 2023, is an innovation-driven technology firm specializing in intelligent oncology diagnostics platform, products, and services.

Our core team, which has concentrated on oncology diagnostics services, brings over 2 decades of validated experience in industry-academia-research integration, sales operations, and commercial management practices within the pathology industry.

We are committed to promoting standardization, integration, and comprehensiveness in oncology diagnostics provision and training. Through our intelligent oncology diagnostics service platform, we empower the full chain of laboratory diagnostics worldwide, including pathology diagnostics, delivering accessible solutions for healthcare institutions, and providing high-standard oncology diagnostics services without regard for geography. We improve our service's coverage and efficiency through resource sharing and cooperative workflow, driving the evolution of next-generation oncology diagnostics ecosystem.

Our Mission：Health within reach

Our Vision：Pioneer of intelligent oncology diagnostics ecosystem

Values：Excellence、Commitment、Innovation、Diligence 、Sustainable Development